An interim analysis reported in…
An interim analysis reported in June showed that Amgen’s Zai [...]
An interim analysis reported in June showed that Amgen’s Zai [...]
Gilead Sciences’ Kite Pharma has cut off a collaboration with [...]
After becoming the first group to therapeutically edit human RNA [...]
After throwing down $70 million upfront to partner on Black [...]
Boston-based Radiance Biopharma is doling out $15 million in cash [...]
Cytokinetics spent Labor Day weekend in Spain, sharing a big [...]
AstraZeneca’s hypertension pill baxdrostat lowered blood pressure by almost 10 [...]
Roche’s hypertension med zilebesiran may have failed to hit the [...]
Zydus Therapeutics has racked up a phase 2b/3 win in [...]
Fosun Pharma has penned its third inflammatory disease pact in [...]